XRF Scientific Limited (ASX:XRF)

XRF Scientific Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	10.38	8.89	7.69	6.08	5.13
Depreciation & Amortization	1.6	1.5	1.11	1.07	1.08
Other Amortization	0.09	0.08	0.09	0.11	0.15
Loss (Gain) From Sale of Assets	0.01	0	-	0.03	-0
Stock-Based Compensation	0.75	0.59	0.33	-	-
Other Operating Activities	-0.28	-0.35	0.31	-0.16	-0
Change in Accounts Receivable	-0.75	-0.89	-2.4	-1.75	-0.71
Change in Inventory	-1.82	-0.14	-1.36	-3.01	-1.22
Change in Accounts Payable	-0.04	0.09	0.93	1.05	0.32
Change in Income Taxes	-0.13	-0.3	0.66	0.15	0.11
Change in Other Net Operating Assets	0.57	-1.78	0.58	-0.53	-0.42
Operating Cash Flow	10.14	8.09	8.42	3.15	4.51
Operating Cash Flow Growth	25.35%	-3.88%	166.86%	-30.09%	7.37%
Capital Expenditures	-1.75	-1.61	-0.76	-0.37	-0.41
Sale of Property, Plant & Equipment	0.89	-	-	0.01	-
Cash Acquisitions	-0.95	-	-	-0.6	-
Sale (Purchase) of Intangibles	-0.4	-0.03	-0.02	-0.15	-0.24
Investing Cash Flow	-2.21	-1.64	-0.78	-1.11	-0.65
Long-Term Debt Issued	-	1.87	2.71	2.08	-
Long-Term Debt Repaid	-1.27	-3.07	-3.92	-0.61	-0.58
Net Debt Issued (Repaid)	-1.27	-1.2	-1.2	1.48	-0.58
Common Dividends Paid	-4.52	-3.6	-2.68	-2.13	-1.65
Other Financing Activities	-1.96	-	-	-	-
Financing Cash Flow	-7.75	-4.8	-3.88	-0.65	-2.24
Net Cash Flow	0.18	1.65	3.75	1.39	1.62
Free Cash Flow	8.39	6.48	7.66	2.78	4.1
Free Cash Flow Growth	29.57%	-15.42%	175.36%	-32.13%	11.89%
Free Cash Flow Margin	14.12%	10.78%	13.86%	6.95%	13.10%
Free Cash Flow Per Share	0.06	0.05	0.06	0.02	0.03
Cash Interest Paid	0.26	0.29	0.22	0.07	0.03
Cash Income Tax Paid	4.59	4.46	2.97	1.84	1.48
Levered Free Cash Flow	6.95	6.08	7.6	2.86	2.8
Unlevered Free Cash Flow	7.11	6.26	7.74	2.9	2.83
Change in Working Capital	-2.38	-3.22	-1.61	-3.98	-1.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.